Patent
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two compa...
July 09, 2021 | News
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...
July 02, 2021 | News
Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of&...
June 25, 2021 | News
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...
June 25, 2021 | News
Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...
June 23, 2021 | News
The patented EYEMATE system is the world’s only clinically-validated product used for comprehensive remote glaucoma monitoring. US FDA Breakthrough D...
June 21, 2021 | News
The new patents, US Patent Nos. 11,020,387 and 11,020,388, expire in September 2032. Orexo will now have nine patents listed in the Orange Book relati...
June 02, 2021 | News
Most Read
Bio Jobs
News
Editor Picks